Short Interest in Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) Drops By 12.4%

Zepp Health Corporation Sponsored ADR (NYSE:ZEPP) was the recipient of a significant decline in short interest in the month of January. As of January 15th, there was short interest totaling 520,263 shares, a decline of 12.4% from the December 31st total of 594,236 shares. Based on an average daily trading volume, of 141,446 shares, the short-interest ratio is presently 3.7 days. Approximately 5.6% of the company’s shares are sold short. Approximately 5.6% of the company’s shares are sold short. Based on an average daily trading volume, of 141,446 shares, the short-interest ratio is presently 3.7 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Ariose Capital Management Ltd purchased a new position in Zepp Health during the third quarter valued at $1,269,000. Trivest Advisors Ltd bought a new position in shares of Zepp Health during the third quarter valued at $13,503,000. Keystone Investors PTE Ltd. purchased a new position in shares of Zepp Health in the 3rd quarter worth about $4,811,000. UBS Group AG boosted its stake in Zepp Health by 16,412.0% in the 3rd quarter. UBS Group AG now owns 181,302 shares of the company’s stock worth $8,300,000 after purchasing an additional 180,204 shares in the last quarter. Finally, Harvest Fund Management Co. Ltd purchased a new stake in Zepp Health during the 3rd quarter valued at about $1,895,000. Institutional investors own 52.61% of the company’s stock.

Zepp Health Stock Performance

Shares of ZEPP stock opened at $18.06 on Tuesday. The company’s fifty day moving average price is $26.38 and its 200-day moving average price is $33.65. The stock has a market cap of $261.78 million, a PE ratio of -4.39 and a beta of 1.45. The company has a current ratio of 1.09, a quick ratio of 0.78 and a debt-to-equity ratio of 0.31. Zepp Health has a 12 month low of $2.13 and a 12 month high of $61.85.

Zepp Health (NYSE:ZEPP) last issued its quarterly earnings results on Wednesday, November 5th. The company reported ($0.04) earnings per share (EPS) for the quarter. The business had revenue of $75.79 million for the quarter. Zepp Health had a negative net margin of 28.28% and a negative return on equity of 21.45%.

Analysts Set New Price Targets

Several analysts recently weighed in on the stock. Weiss Ratings reiterated a “sell (d-)” rating on shares of Zepp Health in a report on Wednesday, January 21st. Fundamental Research set a $64.37 target price on shares of Zepp Health and gave the company a “buy” rating in a research note on Tuesday, November 11th. One research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Zepp Health has a consensus rating of “Hold” and an average target price of $64.37.

About Zepp Health

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.